Results
8555
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,555 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GGP | UK£0.064 | 7.2% | 1.3% | UK£327.3m | n/a | PB6.6x | E48.8% | n/a | Materials | ||
A257720 | ₩45,150.00 | 2.1% | 382.9% | ₩2.7t | ₩63,666.67 | PE33.5x | E45.5% | n/a | Retail | ||
7373 | JP¥1,575.00 | 7.7% | -26.8% | JP¥23.3b | JP¥4,600.00 | PE23.8x | E32.7% | 1.9% | Commercial Services | ||
BOE | AU$3.15 | 17.1% | -33.8% | AU$1.3b | AU$4.49 | PE28.9x | E31.9% | n/a | Energy | ||
9218 | JP¥763.00 | 2.4% | -14.7% | JP¥7.7b | n/a | PE95.2x | E79.6% | n/a | Healthcare | ||
A137400 | ₩54,500.00 | 10.9% | -11.5% | ₩1.3t | ₩85,350.00 | PE13.8x | E35.6% | 0% | Capital Goods | ||
605499 | CN¥229.16 | 1.3% | 27.6% | CN¥91.1b | CN¥265.66 | PE34.4x | E23.1% | 1.1% | Food, Beverage & Tobacco | ||
3006 | CN¥22.72 | -4.5% | 54.2% | CN¥10.0b | CN¥25.50 | PE34.1x | E24.3% | 2.4% | Household | ||
533286 | ₹403.80 | 4.8% | 85.9% | ₹80.4b | ₹485.00 | PE22.9x | E36.5% | 1.5% | Materials | ||
DOMS | ₹2,716.70 | -2.9% | n/a | ₹159.2b | ₹2,523.33 | PE96.8x | E20.1% | 0.09% | Commercial Services | ||
FWRY | ج.م8.33 | 4.8% | 61.1% | ج.م28.4b | ج.م11.44 | PE29.5x | E29.4% | n/a | Diversified Financials | ||
CADLR | NOK 71.00 | -0.7% | 87.5% | NOK 24.9b | NOK 81.94 | PS17.4x | E67.8% | n/a | Capital Goods | ||
A179900 | ₩22,700.00 | 9.4% | -19.6% | ₩359.2b | ₩60,000.00 | PS18x | E134.6% | 0% | Tech | ||
SCOL | SEK 0.14 | 2.2% | -90.8% | SEK 32.5m | n/a | PB0.7x | E75.3% | n/a | Pharmaceuticals & Biotech | ||
A067310 | ₩11,730.00 | 2.4% | -46.3% | ₩707.2b | ₩21,898.55 | PB2.5x | E100.3% | 0.4% | Semiconductors | ||
MX1 | AU$0.069 | 27.8% | -42.5% | AU$40.1m | n/a | PS2.6x | E86.1% | n/a | Healthcare | ||
ACI | ₹687.90 | -2.3% | 17.8% | ₹84.9b | ₹878.71 | PE31.4x | E33.7% | 0.4% | Materials | ||
9992 | HK$47.05 | -4.5% | 105.9% | HK$62.7b | HK$53.85 | PE36.8x | E29.3% | 0.7% | Retail | ||
CUV | AU$14.32 | -4.4% | -7.4% | AU$717.0m | AU$29.17 | PE20.1x | E27.4% | 0.3% | Pharmaceuticals & Biotech | ||
4480 | JP¥3,510.00 | 13.8% | -30.6% | JP¥114.0b | JP¥5,400.00 | PE42.4x | E30.4% | n/a | Healthcare | ||
NYKAA | ₹198.21 | -0.7% | 32.9% | ₹566.5b | ₹201.00 | PE1467.4x | E36.9% | n/a | Retail | ||
HTL | PK₨33.82 | -9.1% | 52.1% | PK₨4.7b | PK₨63.60 | PB0.8x | E48.3% | 0% | Capital Goods | ||
AGP | €7.14 | 6.4% | 64.1% | €123.6m | €12.75 | PE25.1x | E22.8% | n/a | Capital Goods | ||
3DA | AU$0.38 | 7.0% | 100.0% | AU$206.5m | n/a | PS445.1x | E59.4% | n/a | Capital Goods |